- Home
- MDU vs VKTX Comparison
MDU vs VKTX Comparison
Compare MDU & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDU
- VKTX
- Stock Information
- Founded
- MDU 1924
- VKTX 2012
- Country
- MDU United States
- VKTX United States
- Employees
- MDU N/A
- VKTX N/A
- Industry
- MDU Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- MDU Industrials
- VKTX Health Care
- Exchange
- MDU Nasdaq
- VKTX Nasdaq
- Market Cap
- MDU 3.4B
- VKTX 2.8B
- IPO Year
- MDU N/A
- VKTX 2015
- Fundamental
- Price
- MDU $17.50
- VKTX $27.85
- Analyst Decision
- MDU Strong Buy
- VKTX Buy
- Analyst Count
- MDU 3
- VKTX 12
- Target Price
- MDU $21.67
- VKTX $84.00
- AVG Volume (30 Days)
- MDU 1.2M
- VKTX 4.4M
- Earning Date
- MDU 05-08-2025
- VKTX 04-23-2025
- Dividend Yield
- MDU 2.61%
- VKTX N/A
- EPS Growth
- MDU N/A
- VKTX N/A
- EPS
- MDU 1.27
- VKTX N/A
- Revenue
- MDU $1,844,536,000.00
- VKTX N/A
- Revenue This Year
- MDU $10.58
- VKTX N/A
- Revenue Next Year
- MDU $3.70
- VKTX N/A
- P/E Ratio
- MDU $13.78
- VKTX N/A
- Revenue Growth
- MDU 91.83
- VKTX N/A
- 52 Week Low
- MDU $13.23
- VKTX $18.92
- 52 Week High
- MDU $20.39
- VKTX $81.81
- Technical
- Relative Strength Index (RSI)
- MDU 60.44
- VKTX 54.95
- Support Level
- MDU $17.33
- VKTX $26.73
- Resistance Level
- MDU $17.56
- VKTX $30.28
- Average True Range (ATR)
- MDU 0.33
- VKTX 1.66
- MACD
- MDU 0.08
- VKTX 0.37
- Stochastic Oscillator
- MDU 75.60
- VKTX 65.19
About MDU MDU Resources Group Inc. (Holding Company)
MDU Resources Group Inc operates in three business segments, which include the electric segment, which generates, transmits, and distributes electricity in Montana, North Dakota, South Dakota, and Wyoming; The natural gas distribution segment distributes natural gas in those states, as well as in Idaho, Minnesota, Oregon, and Washington; The pipeline segment provides natural gas transportation and underground storage services through a regulated pipeline system in the Rocky Mountain and northern Great Plains regions of the United States.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.